This morning, the inauguration ceremony for the production of bioGenous BIOTECH, Inc (Hangzhou) was held at the Transfar Innovation Center in Xiaoshan Innovation Polis.

The inauguration ceremony was hosted by Dr. NI Chao, CEO of bioGenous. Greetings were delivered by GAO Yuan, Deputy Director of the Xiaoshan Innovation Polis Management Committee; CHEN Tao, President of Hangzhou Transfar Innocity.; Professor WANG Xiaoning, mentor to bioGenous (who sent a video message); and Dr. ZHAO Bing, founder of bioGenous.

Also present were CHEN Xingquan, Director of the Management Service Center of Hangzhou Bay Smart Valley (Xiaoshan Haichuang Park); Professors QIAN Pengxu and JIANG Ming, researchers from Zhejiang University's "Hundred Talents Program" and national talent programs; representatives of entrepreneurs from Xiaoshan Innovation City; and employees of bioGenous, all witnessing another highlight moment for the company.

Multi-cancer, whole-process tumor organoids kits

The inauguration ceremony officially announced the launch of bioGenous’ independently developed multi-cancer, whole-process tumor organoid kits, which are now in production.

GAO Yuan, Deputy Director of the Xiaoshan Innovation City Management Committee, delivered a speech

GAO Yuan, Deputy Director of the Xiaoshan Innovation Polis Management Committee, extended warm congratulations to bioGenous on the successful launch of its production and delivered a speech. Director Gao shared his personal impressions of bioGenous’ journey in Xiaoshan Innovation City, describing it with phrases such as "struggles and challenges," "drive and passion," and "ideals and sentiments." Despite the many difficulties, nothing has stopped bioGenous from moving forward. Director Gao expressed his sincere hope that this young team at bioGenous will combine the rational thinking of scientists with a keen understanding of the world, unleashing great strength on the path to national rejuvenation. He encouraged them to let their achievements drive their ambitions, with science and talent leading the trends of the times. In the field of organoid biomedicine, bioGenous is surely destined for a bright future.

CHEN Tao, President of Hangzhou Transfar Innocity, expressed in his speech

CHEN Tao, President of Hangzhou Transfar Innocity, expressed in his subsequent speech how honored he was that such an outstanding project and entrepreneurial team like bioGenous chose their Innovation Center. He also thanked the Management Committee of Xiaoshan Innovation City and Haichuang Park for selecting such an excellent project to be incubated and developed at the Innovation Center.

Video message from Professor WANG Xiaoning, a mentor to bioGenous

Professor WANG Xiaoning, a mentor to bioGenous, was unable to attend the inauguration ceremony due to pandemic control measures, so he recorded a video message. In the video, Professor Wang expressed his heartfelt wishes, hoping that bioGenous will stay true to its original mission, seize the opportunities that this era offers to scientists, and contribute its strength to China's scientific and technological endeavors.

Dr ZHAO Bing delivered the speech

Share session of Dr ZHAO Bing

Dr. ZHAO Bing, founder of bioGenous, delivered a speech and hosted the “Organoids: Revolution in Biomedicine” sharing session as part of the Gravity Hour series. Dr. Zhao highlighted that the growth of bioGenous represents a vivid snapshot of the nation's strong support for scientific and technological innovation, with bioGenous’ DNA being rooted in cutting-edge global technology. Organoid technology, as a revolutionary model that closely simulates human tissues and organs, is at the forefront of today’s life sciences and is driving a major revolution in the biomedicine field. bioGenous will continue to base its development on scientific innovation, strengthen its innovative capacity, respond to the national strategy of innovation-driven development, and consistently deliver world-class organoid technologies, contributing to the health and well-being of the people.

bioGenous Inauguration Ribbon-Cutting Ceremony

After the ribbon-cutting ceremony, the attending guests visited bioGenous exhibition hall, where they gained further insight into the company's technological capabilities, products and services, as well as its research journey.

At this historical juncture where Hangzhou serves as a pioneering demonstration zone for common prosperity, bioGenous will steadfastly maintain its drive for progress and seize the leading position in the organoid biotechnology field. The company will actively promote breakthrough advancements in organoid technology and use its achievements to give back to Xiaoshan’s "5213 Plan" and the strong support from Xiaoshan Innovation Polis, helping to build momentum in the biomedicine sector of Xiaoshan Innovation Polis.

The team at bioGenous will continue to forge ahead with the conviction of researchers, the commitment of the company, and their own contributions to give back to the nation, society, and the people!